Cambridge Forum Opens AI & Health Pitch Applications , Cambridge 2026

Key Points

• Cambridge Forum officially opened applications for “Pitch My Idea: AI and Health” on 27 May 2026
• The pitch event will take place on 11 September 2026 at Cambridge Corn Exchange in Cambridge, England
• Seven pre-seed and seed-stage health tech startups will be selected to pitch to investors
• Each selected founder receives a 7-minute pitch followed by a 7-minute moderated Q&A session
• Target sectors include Clinical Intelligence, Diagnostics, Therapeutics, Remote Care, Health Systems, and Global Health
• Applications close on 1 July 2026 with no application fee
• Pitch coaching and mentoring sessions scheduled for 11 August and 19 August 2026
• Cambridge Forum prioritises ethical AI solutions with measurable positive societal impact
• The organisation encourages applications from women founding teams and diverse backgrounds
• Selected founders receive structured pitch preparation, rehearsal feedback, and curated investor introductions within 48 hours
• Audience includes UK and international investors, academia leaders, healthcare executives, and global institution representatives
• Cambridge Forum describes itself as a global hub for innovation and knowledge exchange

Cambridge(Cambridge Tribune) June 01, 2026 — Cambridge Forum, the global hub for innovation and knowledge exchange, today officially opens applications for Pitch My Idea: AI and Health – a morning of pitch sessions, keynote speeches, panels and networking, as reported in an official press release distributed via PR Newswire on 27 May 2026. This curated opportunity, which connects seven lucky startups with investors, is scheduled for 11th September 2026 at the Cambridge Corn Exchange.

Who Should Apply for Pitch My Idea AI and Health?

As reported by Cambridge Forum in their official announcement, the organisation is seeking startups and spin-outs specialising in AI-driven healthcare solutions. Target sectors include Clinical Intelligence and Diagnostics, Therapeutics and Life Sciences, Remote Care and Personal Health, Health Systems and Operations, Health Data Infrastructure and Governance, and Population and Global Health. Cambridge Forum is particularly interested in solutions that are ethical and have a significant and measurable positive impact on society. The organisation encourages applications from women founding teams and founders from diverse backgrounds.

According to additional details published on Cambridge Forum’s platform, the event invites pre-seed and seed-stage health tech startups to apply for Pitch My Idea, their showcase focused on AI and Health. Building in healthcare is rarely straightforward, with clinical validation taking time, adoption pathways being complex, and regulation, implementation, trust, and evidence all mattering, according to Cambridge Forum’s description of founder challenges. Most founders are navigating all of this while building with limited time and capital, the organisation noted.

What Will Selected Startups Receive From This Pitch Opportunity?

Seven selected startups will deliver a 7-minute pitch followed by a 7-minute moderated Q&A, as detailed by Cambridge Forum. Founders will present to a curated audience of UK and international investors, alongside leaders from academia, healthcare, and global institutions. Selected founders will also receive structured pitch preparation, optional rehearsal and feedback sessions, curated investor introductions within 48 hours, and ongoing post-event support and follow-up.

Cambridge Forum stated they are particularly interested in companies tackling meaningful healthcare challenges through clinically informed innovation, responsible AI adoption, and evidence-led approaches to impact. The event design reflects these realities faced by health tech founders, with the programme built around the complexities of clinical validation and adoption.

When Are the Key Dates and Deadlines for Applications?

The key dates and deadlines for Pitch My Idea: AI and Health are as follows, according to Cambridge Forum’s official announcement:

• Applications Now Open (as of 27 May 2026)
• 1st July 2026: Final Application Deadline
• 11th & 19th August: Pitch coaching and mentoring
• 11th September 2026: Pitch Day at Cambridge Corn Exchange

There is no fee to apply for the programme, Cambridge Forum confirmed. Applications can be submitted through the official Cambridge Forum events page at https://cambridgeforum.com/events/pitch-my-idea/.

Why Does This Event Matter for AI and Health Innovation?

Pitch My Idea is designed with the realities of healthcare innovation in mind, addressing the challenges that most founders face when building in healthcare. In September 2026, seven early-stage health tech founders will take the stage at Cambridge Forum to share what they are building, why it matters, and what it will take to bring their solutions into real clinical and operational settings, according to Cambridge Forum’s event description.

The event connects startups with a curated audience that includes UK and international investors, academic leaders, healthcare executives, and representatives from global institutions. This connection is critical for health tech startups that need both funding and pathways to clinical adoption.

Background on Cambridge Forum and This Development

Cambridge Forum positions itself as a global hub for innovation and knowledge exchange, according to its official press release dated 27 May 2026. The organisation has established itself as a connector between startups, investors, academia, and healthcare institutions in the Cambridge innovation ecosystem. Cambridge is recognised globally as a centre for technology innovation, particularly in life sciences and healthcare technology, making it a strategic location for an AI and health-focused pitch event.

The Pitch My Idea: AI and Health programme represents Cambridge Forum’s focused effort to address the specific challenges faced by health tech founders, including clinical validation timelines, complex adoption pathways, regulatory requirements, and the need for building trust and evidence in healthcare settings. The programme’s emphasis on ethical AI solutions with measurable positive societal impact reflects growing industry focus on responsible AI deployment in healthcare.

The decision to limit participation to seven startups allows for curated investor introductions within 48 hours of the event and ensures each founder receives structured pitch preparation and optional rehearsal feedback sessions. This selective approach contrasts with open pitch events and reflects Cambridge Forum’s strategy of creating meaningful connections rather than simply hosting large-scale networking events.

The programme specifically encourages applications from women founding teams and founders from diverse backgrounds, addressing known diversity gaps in health tech investment and entrepreneurship. The target sectors span the full healthcare value chain from Clinical Intelligence and Diagnostics through to Population and Global Health, indicating Cambridge Forum’s comprehensive approach to health innovation.

Prediction: How This Development Will Affect Health Tech Startups and Investors

This development will significantly affect pre-seed and seed-stage health tech startups seeking funding and market entry pathways in the AI and healthcare sector. Startups in the target sectors – Clinical Intelligence and Diagnostics, Therapeutics and Life Sciences, Remote Care and Personal Health, Health Systems and Operations, Health Data Infrastructure and Governance, and Population and Global Health – will gain access to a curated investor audience that includes both UK and international investors. The structured pitch preparation and rehearsal feedback sessions will improve founders’ presentation skills before facing investors, potentially increasing their success rates in securing funding.

For women founding teams and founders from diverse backgrounds, this programme offers a specific opportunity as Cambridge Forum actively encourages their applications. Given documented disparities in health tech investment allocation to diverse founders, this targeted outreach could help address funding gaps. The no-fee application removes financial barriers that might prevent early-stage startups from participating.

The 1 July 2026 application deadline creates urgency for startups currently developing AI-driven healthcare solutions. Startups that miss this deadline will need to wait for future Cambridge Forum programmes, potentially delaying their access to investor networks and market entry opportunities. The pitch coaching and mentoring sessions on 11 August and 19 August 2026 provide critical preparation time between application closure and the main pitch event.

Investors attending the event will gain early access to seven pre-vetted health tech startups working on clinically informed innovation with responsible AI adoption. The curated nature of the audience means investors can focus on meaningful interactions rather than sifting through large numbers of unvetted opportunities. The 48-hour curated investor introductions following the event accelerate the investment timeline compared to traditional networking events where follow-up can take weeks.

The Cambridge Corn Exchange venue provides a established, professional setting for pitch events, lending credibility to selected startups. This venue choice signals Cambridge Forum’s commitment to creating a high-quality experience for both founders and investors.

For the broader AI and health innovation ecosystem, this programme reinforces Cambridge’s position as a global centre for health tech innovation. The emphasis on ethical AI with measurable positive societal impact aligns with increasing regulatory scrutiny and public concern about AI deployment in healthcare. Startups that demonstrate responsible AI adoption and evidence-led approaches to impact may find themselves better positioned for regulatory approval and market acceptance.

The ongoing post-event support and follow-up that selected founders receive extends the value of participation beyond the single pitch day, potentially improving long-term startup success rates. This continued support addresses the common challenge where startups receive initial interest but struggle with follow-through on investment conversations.